UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases	Hemic and Lymphatic Diseases, Immunoglobulin G4-Related Disease, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Skin and Connective Tissue Diseases, anemia, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune hemolytic anemia, cardiovascular disorder, connective tissue disorder, hematologic disorder, hemolytic anemia, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myositis disease, necrotizing vasculitis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis	Not yet recruiting	Phase 1	2025-05-18		NCT06978738

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changzhou No.2 People's Hospital	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Changzhou No.2 People's Hospital	Changzhou	China	3